Zeria Pharmaceutical Co., Ltd.

4559.T
Drug Manufacturers - Specialty & Generic
2026/08/21 Updated
Market Cap: $596.1M (¥94.8B)
Stock Price: $13.52 (¥2,150)
Exchange Rate: 1 USD = ¥158.98

Notice Regarding Executive Officer Personnel Changes

Effective April 9, 2026, Mr. Kenichi Suzuki is promoted from Executive Officer to Senior Executive Officer while continuing as General Manager of Corporate Planning.

Importance:
Page Updated: April 9, 2026
IR Disclosure Date: April 9, 2026

Key Figures

  • Position Change Date: April 9, 2026
  • Promoted Individual: Kenichi Suzuki
  • New Position: Senior Executive Officer and General Manager of Corporate Planning

AI要約

Overview of Executive Officer Position Change

Zeria Pharmaceutical Co., Ltd. resolved at the Board of Directors meeting held on April 9, 2026, to change the positions of its executive officers. Specifically, Mr. Kenichi Suzuki was promoted from Executive Officer and General Manager of Corporate Planning to Senior Executive Officer and General Manager of Corporate Planning.

Impact on Investors

This position change aims to strengthen the organizational structure, and Mr. Suzuki will continue his role as General Manager of Corporate Planning. While no direct impact on earnings or capital policy has been indicated, this executive strengthening may contribute to enhancing corporate value over the medium to long term.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Zeria Pharmaceutical Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →